Gross Margin
14.09%vs Specialty Chemicals peers Updated Aug 20, 2026Profit Margin
0.70%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
2.59%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
0.50%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
0.98%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
1.53BCNY226.67M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
4.67CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-12.60%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
222.54MCNY33.05M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
43.12MCNY6.40M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
10.72MCNY1.59M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
-17.42%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
-36.09MCNY-5.36M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-129.75MCNY-19.27M · vs all stocks (USD) Updated Aug 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 20, 2026Minority Interest (Equity)
244.97MCNYFY2025 · Dec 31, 2025Revenue
1.57BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.33BCNYFY2025 · Dec 31, 2025Gross Profit
241.80MCNYFY2025 · Dec 31, 2025Operating Income
48.83MCNY7.25M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
8.04MCNYFY2025 · Dec 31, 2025Income Tax Expense
-18.76MCNYFY2025 · Dec 31, 2025Net Income
26.79MCNYFY2025 · Dec 31, 2025EBIT
52.60MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
228.27MCNYFY2025 · Dec 31, 2025Research & Development
71.87MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
37.39MCNYFY2025 · Dec 31, 2025Other Operating Expenses
11.17MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.96MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
44.56MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0578CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0578CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
325.65MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
325.65MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
26.79MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-7.97MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-297.58MCNYFY2025 · Dec 31, 2025Free Cash Flow
-433.60MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
221.03MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
26.79MCNYFY2025 · Dec 31, 2025Other Non-cash Items
44.47MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-341.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-27.63MCNYFY2025 · Dec 31, 2025Capital Expenditures
-136.02MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-240.00MCNYFY2025 · Dec 31, 2025Sale of Investments
241.42MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-134.60MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.03BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-929.30MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-44.18MCNYFY2025 · Dec 31, 2025Other Financing Charges
119.66MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
175.71MCNYFY2025 · Dec 31, 2025